EMERYVILLE, Calif.--(BUSINESS WIRE)--Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced that it can now deliver its Ansa Clonal DNA product in lengths up to 5 ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Ansa Biotechnologies, Inc., a pioneer of next-generation DNA synthesis, today announced that it has synthesized and delivered complex clonal DNA sequences to ...
EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens access to non-coding regions, where most disease-associated genetic variants ...
Ansa Biotechnologies’ CEO Daniel Lin-Arlow’s passion is helping scientists do their job faster and deliver their innovation to the world. His latest solution? Enzymatic DNA synthesis. DNA writing is ...
Last year, during the Global Synthetic Biology (SynBioBeta) conference, Ansa Biotechnologies’ CEO Jason Gammack introduced attendees to the company’s first product—600 bp synthetic DNA constructs.